WallStSmart
DMAC

DiaMedica Therapeutics Inc

NASDAQ: DMAC · HEALTHCARE · BIOTECHNOLOGY

$6.05
+1.51% today

Updated 2026-04-30

Market cap
$341.08M
P/E ratio
P/S ratio
66.68x
EPS (TTM)
$-0.70
Dividend yield
52W range
$3 – $10
Volume
0.2M

DiaMedica Therapeutics Inc (DMAC) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-801159.00$-1.21M$-1.47M$-2.15M$-2.38M$-3.44M$-5.48M$-5.50M$-3.76M$-1.37M$-3.02M$-3.90M$-5.70M$-9.10M$-9.19M$-12.25M$-11.51M$-18.73M$-22.08M$-29.06M
Capital expenditures$108894.00$296168.00$85262.00$92088.00$57763.00$79310.00$63371.00$134270.00$31328.00$5388.00$6893.00$22000.00$50000.00$2000.00$47000.00$22000.00$81000.00$24000.00$25000.00$40000.00
Depreciation
Stock-based comp$155331.00$252398.00$294486.00$1.03M$704573.00$343303.00$125487.00$263310.00$409000.00$620000.00$1.16M$1.84M$1.56M$1.50M$1.68M$2.08M$3.85M
Free cash flow$-910053.00$-1.51M$-1.55M$-2.24M$-2.43M$-3.52M$-5.55M$-5.64M$-3.79M$-1.37M$-3.03M$-3.92M$-5.75M$-9.10M$-9.23M$-12.27M$-11.59M$-18.75M$-22.10M$-29.10M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$0.00$0.00$0.00$15.47M$-12.94M$3.53M